Drug Adherence in Hypertension and Cardiovascular Protection
This book provides a critical and comprehensive review of the methodologies available for measuring drug adherence in clinical practice, including those relying on emerging technologies. The authors discuss the risk factors of non-adherence and shed light on how to identify patients at risk of poor...
Uloženo v:
| Médium: | Elektronický zdroj E-kniha |
|---|---|
| Jazyk: | angličtina |
| Vydáno: |
Cham :
Springer International Publishing,
2018.
|
| Vydání: | 1st ed. 2018. |
| Edice: | Updates in Hypertension and Cardiovascular Protection,
|
| Témata: | |
| ISBN: | 9783319765938 |
| ISSN: | 2366-4606 |
| On-line přístup: |
|
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
Obsah:
- 1 Taxonomy of adherence
- I Measuring drug adherence
- 2 Qualitative assessment of adherence
- 3 Electronic monitoring of drug adherence
- 4 Measurements of drugs in plasma/urine
- 5 Assessing adherence measurement in large databases
- 6 Direct observed treatment in hypertension
- 7 Novel technologies for following drug adherence
- 8 Ethical aspects of measuring adherence II Risk factors for non-adherence
- 9 Determinants and barriers to adherence in CV diseases
- 10 Beliefs and adherence
- III Adherence in hypertension and CV protection
- 11 Impact of drug adherence in clinical trials
- 12 Drug adherence in essential hypertension: impact of drugs
- 13 Persistence in hypertension in general practice
- 14 Drug adherence in resistant hypertension
- 15 Drug adherence with cardiovascular medicines (statins)
- 16 Adherence and cardiovascular risk
- IV Interventions to improve drug adherence
- 17 Which interventions are useful?
- 18 Use of fixed-dose combinations in CV disease prevention
- 19 Nurse-led intervention in Hypertension
- 20 Role of the Pharmacist in supporting adherence
- 21 Integrated approaches to support adherence
- 22 Use of Apps to improve drug adherence
- V Health care consequences of non-adherence
- 23 Global clinical consequence of poor adherence
- 24 Cost of non-adherence.